Health policy on drug trials in paediatric patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1363, 2002-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug trials in paediatric patients: continuing issues

By  

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

It appears that few drug companies are willing to conduct trials in paediatric patients voluntarily

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Info on paediatric drug safety released by Health Canada

By  

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The DEC-net European register of paediatric drug therapy trials: contents and context

By Pandolfini Chiara  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 611-617

Springer Publishing Company

Access to resources Recommend Favorite

Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients

By Mary E. Temple   Renee F. Robinson   Julie C. Miller   John R. Hayes   Milap C. Nahata  

Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. : 819-829

Adis International

Access to resources Recommend Favorite